First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 9.6% of the 110,806 shares held after it.
6 other insiders sold within 30 days.
140 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer & Pres Silberhorn Ty R sold about $673.8K of APOG on May 2, 2024; 6 other insiders sold within 30 days and 140 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Apr 23, 2024.
The trade is 11.7% of the 30,369 shares held after it.
6 other insiders sold within 30 days.
140 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP & CHRO Dobler Curtis John sold about $222.4K of APOG on May 2, 2024; 6 other insiders sold within 30 days and 140 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Apr 14, 2020.
The trade is 9230.8% of the 260 shares held after it.
6 other insiders sold within 30 days.
140 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Johnson Lloyd Emerson sold about $1.5M of APOG on May 2, 2024, the largest insider sale at the company on our record; 6 other insiders sold within 30 days and 140 funds added in the latest 13F quarter.
5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Jul 12, 2023.
The trade is 11363.6% of the 66 shares held after it.
6 other insiders sold within 30 days.
140 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President, Architectural Glass Jewell Brent C sold about $463.4K of APOG on Apr 30, 2024; 6 other insiders sold within 30 days and 140 funds added in the latest 13F quarter.
28 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
APOG planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Wagner Patricia K
Filed 2026-10-13
$219.0K
Wagner Patricia K
Filed 2026-10-13
$1.0M
Jewell Brent C
Filed 2026-06-24
$405.9K
APOG mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Keeley Gabelli Small Cap Dividend Fund
$3.9M position · as of 2026-06-30
1.4%
Keeley Small Cap Fund
$1.8M position · as of 2026-06-30
1.2%
Acquirers Small and Micro Deep Value ETF
$278.6K position · as of 2026-05-31
1.1%
ProShares Russell 2000 Dividend Growers ETF
$6.8M position · as of 2026-05-31
1.0%
Cambria Micro and SmallCap Shareholder Yield ETF
$300.8K position · as of 2026-07-31
0.9%
Invesco S&P SmallCap High Dividend Low Volatility ETF
$638.9K position · as of 2026-05-31
0.9%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Ty RSilberhorn
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2024
$5.3M
$4.0M
$1.6M
+39%
+47%
2023
$5.5M
$4.8M
$413.4K
+62%
+36%
2022
$4.0M
$5.0M
$1.1M
+28%
+10%
2021
$3.2M
$4.0M
$1.2M
+24%
+2%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows 140 funds added last quarter, $1.2M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.4B
four quarters, 2025-08-31 to 2026-08-29
Revenue, TTM APOG
FY Feb 2026
$1.4B
FY Mar 2025
$1.4B
FY Mar 2024
$1.4B
FY Feb 2023
$1.4B
FY Feb 2022
$1.3B
Aug 2026
$391.1M
May 2026
$342.7M
Feb 2026
$351.4M
Nov 2025
$348.6M
Aug 2025
$358.2M
May 2025
$346.6M
Mar 2025
$345.7M
Nov 2024
$341.3M
At each fiscal year end
Single quarter
Net margin, TTM
+4.7%
net income over revenue, 2025-08-31 to 2026-08-29
Net margin, TTM APOG
FY Feb 2026
+3.9%
FY Mar 2025
+6.2%
FY Mar 2024
+7.0%
FY Feb 2023
+7.2%
FY Feb 2022
+0.3%
Aug 2026
+5.7%
May 2026
+3.4%
Feb 2026
+4.7%
Nov 2025
+4.7%
Aug 2025
+6.6%
May 2025
-0.8%
Mar 2025
+0.7%
Nov 2024
+6.1%
At each fiscal year end
Single quarter
Free cash flow, TTM
$95.2M
operating cash flow minus capex, 2025-08-31 to 2026-08-29
Free cash flow, TTM APOG
FY Feb 2026
$95.2M
FY Mar 2025
$89.6M
FY Mar 2024
$161.0M
FY Feb 2023
$57.5M
FY Feb 2022
$78.6M
Aug 2026
$24.3M
May 2026
$1.1M
Feb 2026
$46.9M
Nov 2025
$22.9M
Aug 2025
$52.4M
May 2025
-$26.9M
Mar 2025
$19.1M
Nov 2024
$22.0M
At each fiscal year end
Single quarter
Debt to equity
0.64x
long-term 2026-08-29 plus current 2023-02-25 (42 months older than the period end); equity 2026-08-29
Debt to equity APOG
FY Feb 2026
0.45x
FY Mar 2025
0.58x
FY Mar 2024
0.13x
FY Feb 2023
0.43x
FY Feb 2022
0.42x
Aug 2026
0.64x
May 2026
0.46x
Feb 2026
0.45x
Nov 2025
0.50x
Aug 2025
0.54x
May 2025
0.65x
Mar 2025
0.58x
Nov 2024
0.52x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.38x
TTM operating cash flow over long-term 2026-08-29 plus current 2023-02-25 (42 months older than the period end)
Cash flow to debt APOG
FY Feb 2026
0.53x
FY Mar 2025
0.44x
FY Mar 2024
3.29x
FY Feb 2023
0.60x
FY Feb 2022
0.62x
Aug 2026
0.38x
May 2026
0.63x
Feb 2026
0.53x
Nov 2025
0.38x
Aug 2025
0.36x
May 2025
0.32x
Mar 2025
0.44x
Nov 2024
0.63x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+13.1%
TTM net income over average of 2025-08-30 and 2026-08-29
Return on equity APOG
FY Feb 2026
+10.8%
FY Mar 2025
+17.7%
FY Mar 2024
+23.0%
FY Feb 2023
+26.6%
FY Feb 2022
+0.8%
Aug 2026
+13.1%
May 2026
+13.8%
Feb 2026
+10.8%
Nov 2025
+7.7%
Aug 2025
+8.8%
May 2025
+10.7%
Mar 2025
+17.7%
Nov 2024
+20.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+5.6%
TTM net income over average of 2025-08-30 and 2026-08-29
Return on assets APOG
FY Feb 2026
+4.7%
FY Mar 2025
+8.3%
FY Mar 2024
+11.1%
FY Feb 2023
+11.5%
FY Feb 2022
+0.4%
Aug 2026
+5.6%
May 2026
+6.1%
Feb 2026
+4.7%
Nov 2025
+3.5%
Aug 2025
+4.3%
May 2025
+5.0%
Mar 2025
+8.3%
Nov 2024
+9.5%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+9.1%
operating income after a 28.2% effective tax rate, over long-term 2026-08-29 plus current 2023-02-25 (42 months older than the period end) plus average of 2025-08-30 and 2026-08-29 minus cash
Return on invested capital APOG
FY Feb 2026
+8.5%
FY Mar 2025
+12.3%
FY Mar 2024
+22.1%
FY Feb 2023
+21.1%
FY Feb 2022
n/a
Aug 2026
+9.1%
May 2026
+10.3%
Feb 2026
+8.5%
Nov 2025
+6.2%
Aug 2025
+6.9%
May 2025
+7.6%
Mar 2025
+12.3%
Nov 2024
+14.0%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+11.0%
operating income (EBIT proxy) over average of 2025-08-30 and 2026-08-29 minus current liabilities
Return on capital employed APOG
FY Feb 2026
+9.7%
FY Mar 2025
+15.4%
FY Mar 2024
+20.4%
FY Feb 2023
+18.9%
FY Feb 2022
+3.0%
Aug 2026
+11.0%
May 2026
+10.9%
Feb 2026
+9.7%
Nov 2025
+7.2%
Aug 2025
+8.7%
May 2025
+10.7%
Mar 2025
+15.4%
Nov 2024
+17.0%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
13.95x
close 2026-10-26 over four quarters of diluted EPS, 2025-08-31 to 2026-08-29
P/E, trailing APOG
FY Feb 2026
15.80x
FY Mar 2025
12.29x
FY Mar 2024
12.66x
FY Feb 2023
9.87x
FY Feb 2022
325.21x
Aug 2026
12.76x
May 2026
12.04x
Feb 2026
15.80x
Nov 2025
19.47x
Aug 2025
21.35x
May 2025
16.38x
Mar 2025
12.29x
Nov 2024
18.80x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$1.2B
market value at close 2026-10-26 on 2026-10-02 shares, plus long-term 2026-08-29 plus current 2023-02-25 (42 months older than the period end), minus cash 2026-08-29
Enterprise value APOG
FY Feb 2026
$1.0B
FY Mar 2025
$1.3B
FY Mar 2024
$1.3B
FY Feb 2023
$1.2B
FY Feb 2022
$1.3B
Aug 2026
$1.1B
May 2026
$1.0B
Feb 2026
$1.0B
Nov 2025
$996.9M
Aug 2025
$1.2B
May 2025
$1.1B
Mar 2025
$1.3B
Nov 2024
$2.1B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+10.3%
TTM free cash flow over market value at close 2026-10-26
FCF yield APOG
FY Feb 2026
+11.1%
FY Mar 2025
+8.5%
FY Mar 2024
+12.8%
FY Feb 2023
+5.6%
FY Feb 2022
+6.9%
Aug 2026
+11.3%
May 2026
+15.1%
Feb 2026
+11.1%
Nov 2025
+8.6%
Aug 2025
+7.0%
May 2025
+7.8%
Mar 2025
+8.5%
Nov 2024
+7.0%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.26x
P/E over trailing EPS growth of 53%: four quarters to 2026-08-29 against the four to 2025-08-30
PEG, trailing APOG
FY Feb 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Feb 2023
0.00x
FY Feb 2022
n/a
Aug 2026
0.24x
May 2026
0.34x
Feb 2026
n/a
Nov 2025
n/a
Aug 2025
n/a
May 2025
n/a
Mar 2025
n/a
Nov 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
APOG ranks highest on financial health (64th percentile) and profitability (61st), and lowest on growth (45th), among Materials peers.
Profitability
61
Inputs
Return on equity+13.1% · 68 pct, sector of 100
Return on assets+5.6% · 67 pct, sector of 120
Return on invested capital+9.1% · 42 pct, sector of 37
Return on capital employed+11.0% · 67 pct, sector of 96
Financial health
64
Inputs
Debt to equity0.64x · 52 pct, sector of 104
Cash flow to debt0.38x · 75 pct, sector of 103
Growth
45
Inputs
Revenue growth, YoY+3.2% · 61 pct, sector of 128
Backlog growth, YoY-10.3% · 28 pct, universe of 854
Institutional and government
56
Inputs
Funds adding, latest quarter140 · 56 pct, sector of 118
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
61
Inputs
Short interest, % of float+3.9% · 58 pct, sector of 143
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 103
New text in Risk Factors, latest 10-K+17.4% · 24 pct, sector of 111
2 not measured: Insider conviction, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
APOG filings, in plain words
Are there planned insider sales of APOG?
Yes. 2 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $1.2M of stock; the latest, by Wagner Patricia K, was filed 2026-10-13.
Read the full summary
Insiders filed 2 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $1.2M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.